Abstract
Twenty-one patients with primary unknown cervical lymph node metastases were treated with radiotherapy from October, 1982 to August, 2000. The cause-specific survival rate at 5 year was 20.8% (the median survival rate was 12.3 months). We analyzed treatment outcomes and prognostic factors. We conclude that PS is an important prognostic factor and pathological diagnosis of squamous cell carcinoma, a total dose more than 60Gy and the admistration of hyperthermia can be useful factors.
| Original language | English |
|---|---|
| Pages (from-to) | 1134-1138 |
| Number of pages | 5 |
| Journal | Japanese Journal of Clinical Radiology |
| Volume | 49 |
| Issue number | 9 |
| Publication status | Published - Oct 4 2004 |
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging
Fingerprint Dive into the research topics of 'Radiotherapy of primary unknown cervical lymph node metastases'. Together they form a unique fingerprint.
Cite this
Yahara, K., Nomoto, S., Ohguri, T., Kato, F., Imada, H., Korogi, Y., Terashima, H., Kudo, K., & Yoshida, M. (2004). Radiotherapy of primary unknown cervical lymph node metastases. Japanese Journal of Clinical Radiology, 49(9), 1134-1138.